Wolverine Trading
BIO icon

Wolverine Trading’s Bio-Rad Laboratories Class A BIO Stock Holding History

Wolverine Trading’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,500
Closed -$865K – 4492
2024
Q1 		$865K Buy
+2,500
New +$822K ﹤0.01% 2328
2023
Q4 		– Sell
-1,000
Closed -$358K – 4492
2023
Q3 		$358K Sell
1,000
-400
-29% -$154K ﹤0.01% 3113
2023
Q2 		$525K Buy
1,400
+500
+56% +$203K ﹤0.01% 2555
2023
Q1 		$425K Buy
+900
New +$421K ﹤0.01% 2657
2022
Q3 		– Sell
-500
Closed -$248K – 4600
2022
Q2 		$248K Buy
+500
New +$260K ﹤0.01% 3297
2021
Q4 		– Sell
-1,300
Closed -$974K – 5878
2021
Q3 		$974K Buy
+1,300
New +$974K ﹤0.01% 3022
2021
Q2 		– Sell
-2,000
Closed -$1.13M – 5995
2021
Q1 		$1.13M Buy
2,000
+200
+11% +$118K ﹤0.01% 2594
2020
Q4 		$1.03M Buy
1,800
+600
+50% +$342K ﹤0.01% 2338
2020
Q3 		$618K Sell
1,200
-1,100
-48% -$557K ﹤0.01% 2580
2020
Q2 		$994K Sell
2,300
-2,800
-55% -$1.24M ﹤0.01% 1998
2020
Q1 		$1.78M Buy
5,100
+4,100
+410% +$1.51M 0.01% 1444
2019
Q4 		$370K Sell
1,000
-800
-44% -$282K ﹤0.01% 3347
2019
Q3 		$601K Buy
1,800
+700
+64% +$228K ﹤0.01% 2440
2019
Q2 		$344K Sell
1,100
-6,300
-85% -$1.89M ﹤0.01% 3119
2019
Q1 		$2.26M Buy
7,400
+5,500
+289% +$1.48M 0.01% 1436
2018
Q4 		$436K Buy
+1,900
New +$510K ﹤0.01% 2768
2017
Q1 		– Sell
-3,900
Closed -$711K – 4257
2016
Q4 		$711K Sell
3,900
-1,400
-26% -$239K ﹤0.01% 2235
2016
Q3 		$858K Buy
+5,300
New +$804K ﹤0.01% 2025

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

Wolverine Trading's BIO Position: Q4 2021 in Review

Wolverine Trading sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2021, closing a stake of 1,920 shares — an estimated $1.44M sold.

Wolverine Trading first reported a position in BIO in Q3 2016 and held it in 6 quarters. The position peaked at $1.44M in Q3 2021. 533 funds tracked by Wall St. Rank hold BIO as of Q4 2021.

  • Wolverine Trading reported no remaining Bio-Rad Laboratories Class A position as of Q4 2021 after selling out during the quarter.
  • Wolverine Trading sold 1,920 Bio-Rad Laboratories Class A shares in Q4 2021, an estimated $1.44M.
  • Wolverine Trading first reported a position in Bio-Rad Laboratories Class A in Q3 2016 and held it in 6 quarters.
  • Wolverine Trading's Bio-Rad Laboratories Class A position peaked at $1.44M in Q3 2021.
  • 533 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2021.

Based on Wolverine Trading's 13F filing for Q4 2021, filed 14 Feb 2022.